In Brief Dennis Slamon receives Szent-Györgyi Prize from National Foundation for Cancer Research June 07, 2024Vol.50 No.23
In Brief Susan Bullman, Xi Chen named associate members of MD Anderson’s Allison Institute June 07, 2024Vol.50 No.23
In Brief Harpreet Singh departs FDA, joins Precision for Medicine as chief medical officer June 07, 2024Vol.50 No.23
In Brief Nominate an emerging leader in IO for SITC’s Steven A. Rosenberg Scholars Award June 07, 2024Vol.50 No.23
Clinical Roundup Black patients who receive docetaxel for breast cancer experience less peripheral neuropathy than those who receive paclitaxel June 07, 2024Vol.50 No.23
Clinical Roundup Sarclisa combination improves PFS in newly diagnosed transplant-ineligible MM in phase III trial June 07, 2024Vol.50 No.23
Clinical Roundup Enhertu demonstrated median PFS of 13.2 months in IHC 1+ or IHC 2+/ISH- metastatic breast cancer in phase III trial June 07, 2024Vol.50 No.23
Clinical Roundup Opdivo + Yervoy improves OS for advanced hepatocellular carcinoma in phase III trial June 07, 2024Vol.50 No.23
Clinical Roundup Updated analyses from 3 phase III trials continue to support Opdivo and its combinations for NSCLC June 07, 2024Vol.50 No.23
Clinical Roundup Proton therapy demonstrates advantages for head and neck cancer in phase III trial preliminary data June 07, 2024Vol.50 No.23
